GERD: latest update on acid-suppressant drugs
2024; Elsevier BV; Volume: 7; Linguagem: Inglês
10.1016/j.crphar.2024.100198
ISSN2590-2571
AutoresZyad Al-Frejat, Nafiza Martini, A.M. Esper, Diana Al-Frejat, Samer Younes, Majd Hanna,
Tópico(s)Gastrointestinal motility and disorders
ResumoGERD is a very familiar diagnosis among health care providers due to its massive spread, and its symptoms can affect the quality of life for a respectable slice of its patients. Therefore, what can only be described as a logical consequence, a pursuit of a treatment that can both relieve symptoms and have minimal side effects is still ongoing to cover the large demographic affected by GERD. In the following review, analysis will be made of GERD, including possible regulatory activity, of certain drugs to the already discussed pathways involved in GERD patients.
Referência(s)